{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T02:31:09Z","timestamp":1793327469923,"version":"4.5.0"},"reference-count":56,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2027,3,1]],"date-time":"2027-03-01T00:00:00Z","timestamp":1803859200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2027,3,1]],"date-time":"2027-03-01T00:00:00Z","timestamp":1803859200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T00:00:00Z","timestamp":1789603200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100020595","name":"National Science and Technology Council","doi-asserted-by":"publisher","award":["NSTC 114-2223-E-007-007"],"award-info":[{"award-number":["NSTC 114-2223-E-007-007"]}],"id":[{"id":"10.13039\/100020595","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100020595","name":"National Science and Technology Council","doi-asserted-by":"publisher","award":["NSTC 113-2223-E-007-014"],"award-info":[{"award-number":["NSTC 113-2223-E-007-014"]}],"id":[{"id":"10.13039\/100020595","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004391","name":"China Medical University Hospital","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004391","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005057","name":"National Tsing Hua University","doi-asserted-by":"publisher","award":["114QF042E1"],"award-info":[{"award-number":["114QF042E1"]}],"id":[{"id":"10.13039\/501100005057","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomaterials"],"published-print":{"date-parts":[[2027,3]]},"DOI":"10.1016\/j.biomaterials.2026.124634","type":"journal-article","created":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T17:23:08Z","timestamp":1789665788000},"page":"124634","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"PA","title":["Targeted BRD4 degradation by multivalent dendrimer-based PROTAC and its combined effects with chemotherapy on colon cancer"],"prefix":"10.1016","volume":"338","author":[{"given":"Ramalingam","family":"Sharmila","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weng Chi","family":"Iong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I-Lin","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arjun","family":"Sabu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chun-Liang","family":"Lo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mina Ming-yin","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5509-2107","authenticated-orcid":false,"given":"Hsin-Cheng","family":"Chiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.biomaterials.2026.124634_bib1","doi-asserted-by":"crossref","first-page":"4441","DOI":"10.1038\/s41467-021-24687-4","article-title":"Stromal induction of BRD4 phosphorylation results in chromatin remodeling and BET inhibitor resistance in colorectal cancer","volume":"12","author":"Wang","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.biomaterials.2026.124634_bib2","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1038\/s41392-020-0116-z","article-title":"Comprehensive review of targeted therapy for colorectal cancer","volume":"5","author":"Xie","year":"2020","journal-title":"Signal Transduct. Targeted Ther."},{"key":"10.1016\/j.biomaterials.2026.124634_bib3","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1001\/jama.2021.0106","article-title":"Diagnosis and treatment of metastatic colorectal cancer: a review","volume":"325","author":"Biller","year":"2021","journal-title":"JAMA"},{"key":"10.1016\/j.biomaterials.2026.124634_bib4","doi-asserted-by":"crossref","DOI":"10.1016\/j.drup.2024.101152","article-title":"Breaking the barrier: epigenetic strategies to combat platinum resistance in colorectal cancer","volume":"77","author":"Luo","year":"2024","journal-title":"Drug Resist. Updates"},{"key":"10.1016\/j.biomaterials.2026.124634_bib5","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.drup.2011.08.001","article-title":"Epigenetics and chemoresistance in colorectal cancer: an opportunity for treatment tailoring and novel therapeutic strategies","volume":"14","author":"Crea","year":"2011","journal-title":"Drug Resist. Updates"},{"key":"10.1016\/j.biomaterials.2026.124634_bib6","article-title":"BRD4-directed super-enhancer organization of transcription repression programs links to chemotherapeutic efficacy in breast cancer","volume":"119","author":"Liu","year":"2022","journal-title":"Proc. Natl. Acad. Sci. U. S. A"},{"key":"10.1016\/j.biomaterials.2026.124634_bib7","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1038\/s41392-023-01647-6","article-title":"Bromodomain and extraterminal (BET) proteins: biological functions, diseases, and targeted therapy","volume":"8","author":"Wang","year":"2023","journal-title":"Signal Transduct. Targeted Ther."},{"key":"10.1016\/j.biomaterials.2026.124634_bib8","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1038\/s41419-022-05505-1","article-title":"Regulation of programmed cell death by Brd4","volume":"13","author":"Hu","year":"2022","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.biomaterials.2026.124634_bib9","doi-asserted-by":"crossref","first-page":"1776","DOI":"10.1093\/annonc\/mdx157","article-title":"BET inhibitors: a novel epigenetic approach","volume":"28","author":"Doroshow","year":"2017","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.biomaterials.2026.124634_bib10","article-title":"Targeted protein degradation in cancers: orthodox PROTACs and beyond","volume":"4","author":"Li","year":"2023","journal-title":"Innovation"},{"key":"10.1016\/j.biomaterials.2026.124634_bib11","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1038\/s41419-020-03015-6","article-title":"The therapeutic effect of the BRD4-degrading PROTAC A1874 in human Colon cancer cells","volume":"11","author":"Qin","year":"2020","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.biomaterials.2026.124634_bib12","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1038\/s41392-024-02004-x","article-title":"Targeted protein degradation: advances in drug discovery and clinical practice","volume":"9","author":"Zhong","year":"2024","journal-title":"Signal Transduct. Targeted Ther."},{"key":"10.1016\/j.biomaterials.2026.124634_bib13","doi-asserted-by":"crossref","first-page":"1942","DOI":"10.7150\/ijbs.34162","article-title":"BRD4 inhibitor AZD5153 suppresses the proliferation of colorectal cancer cells and sensitizes the anticancer effect of PARP inhibitor","volume":"15","author":"Zhang","year":"2019","journal-title":"Int. J. Biol. Sci."},{"key":"10.1016\/j.biomaterials.2026.124634_bib14","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1042\/EBC20170041","article-title":"Molecular recognition of ternary complexes: a new dimension in the structure-guided design of chemical degraders","volume":"61","author":"Hughes","year":"2017","journal-title":"Essays Biochem."},{"key":"10.1016\/j.biomaterials.2026.124634_bib15","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.cbpa.2019.02.022","article-title":"Targeted protein degradation: elements of PROTAC design","volume":"50","author":"Paiva","year":"2019","journal-title":"Curr. Opin. Chem. Biol."},{"key":"10.1016\/j.biomaterials.2026.124634_bib16","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1038\/s41392-022-00966-4","article-title":"Targeted protein degradation: mechanisms, strategies and application","volume":"7","author":"Zhao","year":"2022","journal-title":"Signal Transduct. Targeted Ther."},{"key":"10.1016\/j.biomaterials.2026.124634_bib17","doi-asserted-by":"crossref","DOI":"10.1002\/anie.202414146","article-title":"Self-assembled peptide-derived proteolysis-targeting chimera (PROTAC) nanoparticles for tumor-targeted and durable PD-L1 degradation in cancer immunotherapy","volume":"64","author":"Moon","year":"2025","journal-title":"Angew. Chem., Int. Ed. Engl."},{"key":"10.1016\/j.biomaterials.2026.124634_bib18","doi-asserted-by":"crossref","DOI":"10.1002\/anie.202306824","article-title":"Stimuli-responsive PROTACs for controlled protein degradation","volume":"62","author":"An","year":"2023","journal-title":"Angew. Chem., Int. Ed. Engl."},{"key":"10.1016\/j.biomaterials.2026.124634_bib19","article-title":"Revolutionizing protein degradation: harnessing nanoparticles for PROTAC delivery","volume":"37","author":"Fan","year":"2026","journal-title":"Mater. Today Bio"},{"key":"10.1016\/j.biomaterials.2026.124634_bib20","doi-asserted-by":"crossref","first-page":"5974","DOI":"10.1038\/s41467-025-61175-5","article-title":"In situ construction of intracellular supramolecular assemblies as an alternative strategy for protein degradation","volume":"16","author":"Hu","year":"2025","journal-title":"Nat. Commun."},{"key":"10.1016\/j.biomaterials.2026.124634_bib21","doi-asserted-by":"crossref","first-page":"4145","DOI":"10.1021\/acschemneuro.9b00347","article-title":"Surface-modified G4 PAMAM dendrimers cross the blood-brain barrier following multiple tail-vein injections in C57BL\/6J mice","volume":"10","author":"Srinageshwar","year":"2019","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.biomaterials.2026.124634_bib22","doi-asserted-by":"crossref","first-page":"927","DOI":"10.3390\/pharmaceutics17070927","article-title":"From structure to function: the promise of PAMAM dendrimers in biomedical applications","volume":"17","author":"Alamos-Musre","year":"2025","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.biomaterials.2026.124634_bib23","doi-asserted-by":"crossref","DOI":"10.1016\/j.eurpolymj.2023.112073","article-title":"Phenylboronic acid conjugated PAMAM G4 dendrimers augmented usnic acid delivery to gastric cancer cells","volume":"192","author":"Kumar Jangid","year":"2023","journal-title":"Eur. Polym. J."},{"key":"10.1016\/j.biomaterials.2026.124634_bib24","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.apmt.2018.05.002","article-title":"PAMAM dendrimers as efficient drug and gene delivery nanosystems for cancer therapy","volume":"12","author":"Abedi-Gaballu","year":"2018","journal-title":"Appl. Mater. Today"},{"key":"10.1016\/j.biomaterials.2026.124634_bib25","doi-asserted-by":"crossref","first-page":"261","DOI":"10.3389\/fphar.2017.00261","article-title":"Impact of dendrimers on solubility of hydrophobic drug molecules","volume":"8","author":"Choudhary","year":"2017","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.biomaterials.2026.124634_bib26","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/j.mattod.2015.06.003","article-title":"PAMAM dendrimers as promising nanocarriers for RNAi therapeutics","volume":"18","author":"Kesharwani","year":"2015","journal-title":"Mater. Today"},{"key":"10.1016\/j.biomaterials.2026.124634_bib27","article-title":"Self-assembling dendrimer nanodrug formulations for decreased hERG-related toxicity and enhanced therapeutic efficacy","volume":"11","author":"Liu","year":"2025","journal-title":"Sci. Adv."},{"key":"10.1016\/j.biomaterials.2026.124634_bib28","doi-asserted-by":"crossref","first-page":"9986","DOI":"10.1021\/acsnano.5b03521","article-title":"The interplay of size and surface functionality on the cellular uptake of sub-10 nm gold nanoparticles","volume":"9","author":"Jiang","year":"2015","journal-title":"ACS Nano"},{"key":"10.1016\/j.biomaterials.2026.124634_bib29","doi-asserted-by":"crossref","first-page":"1536","DOI":"10.1038\/s41401-023-01078-7","article-title":"A new glance at autophagolysosomal-dependent or -independent function of transcriptional factor EB in human cancer","volume":"44","author":"Wang","year":"2023","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.biomaterials.2026.124634_bib30","doi-asserted-by":"crossref","first-page":"1801","DOI":"10.1080\/15548627.2017.1364334","article-title":"BRD4 is a newly characterized transcriptional regulator that represses autophagy and lysosomal function","volume":"13","author":"Wen","year":"2017","journal-title":"Autophagy"},{"key":"10.1016\/j.biomaterials.2026.124634_bib31","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1038\/s41571-021-00549-2","article-title":"The MYC oncogene - the grand orchestrator of cancer growth and immune evasion","volume":"19","author":"Dhanasekaran","year":"2022","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.biomaterials.2026.124634_bib32","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.4161\/cc.7.8.5739","article-title":"The oncogene c-Myc coordinates regulation of metabolic networks to enable rapid cell cycle entry","volume":"7","author":"Morrish","year":"2008","journal-title":"Cell Cycle"},{"key":"10.1016\/j.biomaterials.2026.124634_bib33","doi-asserted-by":"crossref","first-page":"19204","DOI":"10.1073\/pnas.1108977108","article-title":"\u03b2-catenin\/TCF4 complex induces the epithelial-to-mesenchymal transition (EMT)-Activator ZEB1 to regulate tumor invasiveness","volume":"108","author":"S\u00e1nchez-Till\u00f3","year":"2011","journal-title":"Proc. Natl. Acad. Sci. U. S. A"},{"key":"10.1016\/j.biomaterials.2026.124634_bib34","doi-asserted-by":"crossref","first-page":"33972","DOI":"10.18632\/oncotarget.15687","article-title":"The regulation of \u03b2-catenin activity and function in cancer: therapeutic opportunities","volume":"8","author":"Shang","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.biomaterials.2026.124634_bib35","doi-asserted-by":"crossref","first-page":"4083","DOI":"10.1038\/s41467-020-17503-y","article-title":"BRD4 prevents the accumulation of R-loops and protects against transcription-replication collision events and DNA damage","volume":"11","author":"Lam","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.biomaterials.2026.124634_bib36","doi-asserted-by":"crossref","first-page":"3763","DOI":"10.1038\/s41388-018-0194-3","article-title":"BRD4 facilitates replication stress-induced DNA damage response","volume":"37","author":"Zhang","year":"2018","journal-title":"Oncogene"},{"key":"10.1016\/j.biomaterials.2026.124634_bib37","doi-asserted-by":"crossref","first-page":"1841","DOI":"10.1093\/annonc\/mdf337","article-title":"Irinotecan: mechanisms of tumor resistance and novel strategies for modulating its activity","volume":"13","author":"Xu","year":"2002","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.biomaterials.2026.124634_bib38","article-title":"Size-dependent renal filtration model explains human pharmacokinetics of a functional nanoparticle: the SPAGOPIX-01 clinical trial","volume":"62","author":"Axelsson","year":"2024","journal-title":"Nanomedicine"},{"key":"10.1016\/j.biomaterials.2026.124634_bib39","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.biomaterials.2018.01.043","article-title":"Suppress orthotopic colon cancer and its metastasis through exact targeting and highly selective drug release by a smart nanomicelle","volume":"161","author":"Zhu","year":"2018","journal-title":"Biomaterials"},{"key":"10.1016\/j.biomaterials.2026.124634_bib40","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1016\/j.molcel.2014.05.016","article-title":"The mechanisms behind the therapeutic activity of BET bromodomain inhibition","volume":"54","author":"Shi","year":"2014","journal-title":"Mol. Cell"},{"key":"10.1016\/j.biomaterials.2026.124634_bib41","doi-asserted-by":"crossref","first-page":"237","DOI":"10.34133\/bmr.0237","article-title":"Tryptamine-functionalized lipid nanocarriers co-delivering SMO\/BRD4 inhibitors for synergistic medulloblastoma therapy","volume":"29","author":"Wang","year":"2025","journal-title":"Biomater. Res."},{"key":"10.1016\/j.biomaterials.2026.124634_bib42","doi-asserted-by":"crossref","first-page":"148","DOI":"10.34133\/research.0148","article-title":"Advanced strategies for overcoming endosomal\/lysosomal barrier in nanodrug delivery","volume":"6","author":"Qiu","year":"2023","journal-title":"Research"},{"key":"10.1016\/j.biomaterials.2026.124634_bib43","doi-asserted-by":"crossref","DOI":"10.1002\/anie.202520235","article-title":"Ionizable nano-PROTAC overcomes endosomal entrapment for enhanced LRG1 degradation and tumor suppression","volume":"65","author":"Min","year":"2026","journal-title":"Angew. Chem., Int. Ed. Engl."},{"key":"10.1016\/j.biomaterials.2026.124634_bib44","doi-asserted-by":"crossref","first-page":"6645","DOI":"10.1038\/s41467-023-42280-9","article-title":"Nanomechanical action opens endo-lysosomal compartments","volume":"14","author":"Zhao","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.biomaterials.2026.124634_bib45","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1038\/bjc.2011.498","article-title":"Topoisomerase I inhibition in colorectal cancer: biomarkers and therapeutic targets","volume":"106","author":"Gilbert","year":"2012","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.biomaterials.2026.124634_bib46","first-page":"235","article-title":"Mechanisms of resistance to drugs that inhibit DNA topoisomerases","volume":"2","author":"Beck","year":"1991","journal-title":"Semin. Cancer Biol."},{"key":"10.1016\/j.biomaterials.2026.124634_bib47","first-page":"424","article-title":"Human DNA-topoisomerases - diagnostic and therapeutic implications for cancer","volume":"23","author":"Kellner","year":"2000","journal-title":"Onkologie"},{"key":"10.1016\/j.biomaterials.2026.124634_bib48","doi-asserted-by":"crossref","first-page":"8598","DOI":"10.1038\/s41467-025-63685-8","article-title":"Cytoplasmic TRIM24 promotes colorectal cancer cell proliferation by activating Wnt\/\u03b2-catenin signaling","volume":"16","author":"Wang","year":"2025","journal-title":"Nat. Commun."},{"key":"10.1016\/j.biomaterials.2026.124634_bib49","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1038\/s41392-018-0008-7","article-title":"Targeting oncogenic myc as a strategy for cancer treatment","volume":"3","author":"Chen","year":"2018","journal-title":"Signal Transduct. Targeted Ther."},{"key":"10.1016\/j.biomaterials.2026.124634_bib50","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/j.molcel.2017.04.027","article-title":"Bromodomain protein BRD4 is a transcriptional repressor of autophagy and lysosomal function","volume":"66","author":"Sakamaki","year":"2017","journal-title":"Mol. Cell"},{"key":"10.1016\/j.biomaterials.2026.124634_bib51","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1186\/s12943-019-1089-9","article-title":"Role of hypoxia in cancer therapy by regulating the tumor microenvironment","volume":"18","author":"Jing","year":"2019","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.biomaterials.2026.124634_bib52","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-018-31658-1","article-title":"Interplay between interferon regulatory factor 1 and BRD4 in the regulation of PD-L1 in pancreatic stellate cells","volume":"8","author":"Ebine","year":"2018","journal-title":"Sci. Rep."},{"key":"10.1016\/j.biomaterials.2026.124634_bib53","doi-asserted-by":"crossref","DOI":"10.1016\/j.xpro.2021.101018","article-title":"Protocols to monitor TFEB activation following lysosomal damage in cultured cells using microscopy and immunoblotting","volume":"3","author":"Ogura","year":"2022","journal-title":"STAR Protoc."},{"key":"10.1016\/j.biomaterials.2026.124634_bib54","article-title":"cAMP promotes acute lysosome biogenesis through TFEB nuclear import-export dynamics","author":"Bhatt","year":"2025","journal-title":"bioRxivorg"},{"key":"10.1016\/j.biomaterials.2026.124634_bib55","doi-asserted-by":"crossref","first-page":"1534","DOI":"10.1097\/HEP.0000000000001214","article-title":"Ubiquitination of TFEB increased intestinal permeability to aggravate metabolic dysfunction-associated steatohepatitis","volume":"82","author":"Liu","year":"2025","journal-title":"Hepatology"},{"key":"10.1016\/j.biomaterials.2026.124634_bib56","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.biomaterials.2019.01.019","article-title":"Hierarchically targetable polysaccharide-coated solid lipid nanoparticles as an oral chemo\/thermotherapy delivery system for local treatment of Colon cancer","volume":"197","author":"Shen","year":"2019","journal-title":"Biomaterials"}],"container-title":["Biomaterials"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0142961226006587?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0142961226006587?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T01:42:51Z","timestamp":1793324571000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0142961226006587"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2027,3]]},"references-count":56,"alternative-id":["S0142961226006587"],"URL":"https:\/\/doi.org\/10.1016\/j.biomaterials.2026.124634","relation":{},"ISSN":["0142-9612"],"issn-type":[{"value":"0142-9612","type":"print"}],"subject":[],"published":{"date-parts":[[2027,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Targeted BRD4 degradation by multivalent dendrimer-based PROTAC and its combined effects with chemotherapy on colon cancer","name":"articletitle","label":"Article Title"},{"value":"Biomaterials","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biomaterials.2026.124634","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"124634"}}